One year in review 2020: novelties in the treatment of rheumatoid arthritis

E Silvagni, A Giollo, G Sakellariou, N Ughi… - Clinical and …, 2020 - boa.unimib.it
Rheumatoid arthritis (RA) management is driven by evidence, and new 2019 EULAR
recommendations help in refining the relevant place of different disease-modifying anti …

One year in review 2019: novelties in the treatment of rheumatoid arthritis

E Silvagni, M Di Battista, A Bonifacio… - Clinical and …, 2019 - boa.unimib.it
The current treatment approach in rheumatoid arthritis (RA) follows a stepwise management,
starting from early introduction of conventional synthetic (cs) disease-modifying anti …

One year in review 2018: novelties in the treatment of rheumatoid arthritis

A Bortoluzzi, F Furini, E Generali, E Silvagni… - Clinical and …, 2018 - boa.unimib.it
The current approach to treatment of rheumatoid arthritis (RA) includes early and aggressive
intervention aiming to reach early and persistent low disease activity and remission. New …

One year in review 2021: novelties in the treatment of rheumatoid arthritis

E Silvagni, G Sakellariou, A Bortoluzzi… - Clinical and …, 2021 - boa.unimib.it
Management of rheumatoid arthritis (RA) has evolved over the years as a result of better
understanding of the role of different therapeutic strategies, as well as following an …

[PDF][PDF] One year in review 2017: novelties in the treatment of rheumatoid arthritis

F Ferro, E Elefante, N Luciano, R Talarico… - Clin Exp …, 2017 - clinexprheumatol.org
Rheumatoid arthritis (RA) is a chronic disease characterised by inflammation of the synovial
tissue in joints, which can lead to joint destruction. The primary goal of the treatment is to …

[PDF][PDF] One year in review 2016: novelties in the treatment of rheumatoid arthritis

A Calabrò, AL Caterino, E Elefante… - Clin Exp …, 2016 - clinexprheumatol.org
Rheumatoid arthritis (RA) is a chronic disease characterised by inflammation of the synovial
tissue in joints, which can lead to joint destruction. The primary goal of the treatment is to …

Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for …

A Kerschbaumer, A Sepriano, JS Smolen… - Annals of the …, 2020 - ard.bmj.com
Objectives To inform the 2019 update of the European League against Rheumatism
(EULAR) recommendations for the management of rheumatoid arthritis (RA). Methods A …

Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS …

T Frisell, H Bower, M Morin, E Baecklund… - Annals of the …, 2023 - ard.bmj.com
Objective Longitudinal clinical registry-infrastructures such as Anti-Rheumatic Therapies in
Sweden (ARTIS) allow simultaneous comparison of the safety of individual …

Management of rheumatoid arthritis: an overview

AF Radu, SG Bungau - Cells, 2021 - mdpi.com
Rheumatoid arthritis (RA) is a multifactorial autoimmune disease of unknown etiology,
primarily affecting the joints, then extra-articular manifestations can occur. Due to its …

Understanding emerging treatment paradigms in rheumatoid arthritis

FC Breedveld, B Combe - Arthritis Research & Therapy, 2011 - Springer
Abstract Treatment strategies for rheumatoid arthritis (RA) will continue to evolve as new
drugs are developed, as new data become available, and as our potential to achieve greater …